GB906399A - Injectable solutions comprising benzothiadiazine-1:1-dioxide diuretics - Google Patents
Injectable solutions comprising benzothiadiazine-1:1-dioxide diureticsInfo
- Publication number
- GB906399A GB906399A GB144260A GB144260A GB906399A GB 906399 A GB906399 A GB 906399A GB 144260 A GB144260 A GB 144260A GB 144260 A GB144260 A GB 144260A GB 906399 A GB906399 A GB 906399A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- benzothiadiazine
- dioxide
- amides
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
- C07D285/26—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
- C07D285/28—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached in position 3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
An injectable aqueous solution comprises per ml., an effective amount of up to about 0.1 grm. of a benzothiadiazine-1 : 1-dioxide diuretic and about 10 to 40% by weight (of the total) of at least one water-soluble N-substituted amide, the solution being buffered to a pH of about 4 to 7. Optionally, 4-amino-6-chloro-benzene-1 : 3-disulphonamide may be added as stabilizing agent. The diuretics (which may be in the form of their therapeutically useful salts, e.g. those with alkali metals) may be those of general formula <FORM:0906399/VI/1> wherein R1 represents hydrogen, alkyl, halogeno-alkyl, cycloalkyl, monocyclic aryl or monocyclic aryl alkyl; R21, R211 and R2111 represent hydrogen, alkyl or aralkyl and R3 represents halogen, methyl or halogeno-alkyl, e.g. trifluoromethyl, examples being 6-chloro-7-sulphamyl - 3 : 4 - dihydro - [1 : 2 : 4] - benzothiadiazine - 1 : 1 - dioxide and 6 - chloro - 3 - methyl - 7 - sulphamyl - 3 : 4 - dihydro - [1 : 2 : 4]-benzothiadiazine - 1 : 1 - dioxide. The corresponding compounds which contain a C=N double bond in the 3 : 4- or 2 : 3-position are included. Preferred amides are the N-lower (C1-8) alkyl- or N,N-di-lower (C1-8) alkyl amides of aliphatic monocarboxylic acids containing up to 8 carbon atoms, e.g. lower fatty acids and the corresponding halogenated or hydroxylated compounds. Other substituted amides mentioned are those of polye.g. di-carboxylic acids particularly lower alkenyl or alkylene dicarboxylic acids containing up to 4 carbon atoms in the alkenyl or alkylene chain, di- and tetrasubstituted ureas, thioureas, amides of benzene mono- and dicarboxylic acids, e.g. phthalamides, isophthalamides and terephthalamides, N-lower alkylated xanthines and N-substituted amide polymers, e.g. polyvinyl pyrrolidene. The amide group may also be substituted by other aliphatic groups, e.g. b -hydroxyethyl or b -chloroethyl or by aromatic groups, e.g. phenyl, tolyl, chlorophenyl. Antioxidants may also be present. Specifications 847,064 and 861,367 are referred to.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78668859A | 1959-01-14 | 1959-01-14 | |
US81800459A | 1959-06-04 | 1959-06-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB906399A true GB906399A (en) | 1962-09-19 |
Family
ID=27120564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB144260A Expired GB906399A (en) | 1959-01-14 | 1960-01-14 | Injectable solutions comprising benzothiadiazine-1:1-dioxide diuretics |
Country Status (4)
Country | Link |
---|---|
BE (1) | BE586530A (en) |
DE (1) | DE1211751B (en) |
GB (1) | GB906399A (en) |
NL (1) | NL247297A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2320101A1 (en) * | 1975-08-04 | 1977-03-04 | Geistlich Soehne Ag | SOLUTIONS WITH IMPROVED ANTIBACTERIAL ACTION BASED ON THIADIAZINE DERIVATIVES |
EP0154009A1 (en) * | 1983-12-09 | 1985-09-11 | Euro-Celtique S.A. | Use of a thiazide diuretic for the manufacture of a non-diuretic antihypertensive medicament |
-
0
- NL NL247297D patent/NL247297A/xx unknown
-
1960
- 1960-01-09 DE DEC20531A patent/DE1211751B/en active Pending
- 1960-01-13 BE BE586530A patent/BE586530A/en unknown
- 1960-01-14 GB GB144260A patent/GB906399A/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2320101A1 (en) * | 1975-08-04 | 1977-03-04 | Geistlich Soehne Ag | SOLUTIONS WITH IMPROVED ANTIBACTERIAL ACTION BASED ON THIADIAZINE DERIVATIVES |
EP0154009A1 (en) * | 1983-12-09 | 1985-09-11 | Euro-Celtique S.A. | Use of a thiazide diuretic for the manufacture of a non-diuretic antihypertensive medicament |
Also Published As
Publication number | Publication date |
---|---|
DE1211751B (en) | 1966-03-03 |
BE586530A (en) | 1960-07-13 |
NL247297A (en) |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR840008016A (en) | Method for preparing fused imidazole compound | |
ZA833415B (en) | Substituted 5-trifluoromethyl-1,3,4-thiadiazol-2-yl-oxyacetic acid amides,a process for their preparation and their use as herbicides | |
ES425084A2 (en) | Alkyl and cycloalkylthiophenylalkylaminoalkanols, their salts and the preparation thereof | |
ES431514A1 (en) | 2-Heteroaryl-methyl)-5,9{62 -dialkyl-6,7-benzomorphans and salts thereof | |
ES405983A1 (en) | N-fluoroalkylated phenylethylamine | |
GB1291675A (en) | 0-(1,3,4-thiadiazol-2-yl)-imidazolidinone(2) derivatives, process for their production and their use as herbicidal agents | |
GB906399A (en) | Injectable solutions comprising benzothiadiazine-1:1-dioxide diuretics | |
ES8402581A1 (en) | Fungicidal heterocyclic compounds and compositions containing them. | |
JPS5559195A (en) | 3,7-disubstituted-2 or 3-cephem-4-carboxylic acid compound or its salt, their preparation, and preventives and remedies for microbism comprising them as active constituents | |
ES265136A1 (en) | 2-alkyl mercapto-9-(n-alkyl-piperidylidene-4'-thioxanthenes and the acetate salts thereof | |
KR900003179A (en) | Benzodiazepines Compounds and Uses thereof as Pharmaceuticals | |
KR850000455A (en) | Method for preparing cephalosporin ester derivative | |
ES479570A1 (en) | 7 alpha -Methoxycephalosporin derivatives and their pharmaceutical compositions having antibacterial activity | |
KR880012544A (en) | Benzenesulfonamide Derivatives and Preparation Methods Thereof | |
ATE70531T1 (en) | CARBACYCLINESTERS, PROCESSES FOR THEIR PRODUCTION AND THEIR USE IN MEDICINE. | |
HUT42280A (en) | Fungicidal compositions and process for preparing piperazinyl-methyl-1,2,4-triazolyl-methyl-carbinol derivatives applicable as active substance | |
GB1436230A (en) | Method of converting radiation of frequency higher than that of visible light to radiation in the visible range | |
IE38732B1 (en) | O-triazolylthionophosphoric(phosphonic) acid esters and ester-amides, a process for their preparation and their use as insecticides and acaricides | |
ES430900A1 (en) | Substituted indanones | |
ES460117A1 (en) | Sulfur-containing N-benzylamino-acids and salts thereof | |
HUT45016A (en) | Herbicides containing as active substance derivatives of piridil-phenil-ether and process for production of these derivatives | |
ES449446A1 (en) | 1-Oxo-1H-6-piperidinopyrimido{8 1,2-a{9 quinoline-2-carboxylic acids and esters | |
ES418550A1 (en) | O-alkyl-s-alkyl-o-(1-hydrocarbyloxy carbonyl-1-propen-2-yl)dithiophosphates | |
ES270291A1 (en) | Stabilized herbicidal composition and method of employing the same | |
ES275091A1 (en) | Process for the production of dibenzoazepine derivatives |